Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEFF R PETERSON

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1467491076
CMS profile
338227
Location
BOTHELL, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$205,564.86

313 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 4 of 7; records 151–200 of 313 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEFF R PETERSON

NPI 1467491076 · CMS profile ID 338227

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

BOTHELL, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 7; records 151–200 of 313 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467491076?year=2021&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEFF R PETERSON, NPI 1467491076, CMS profile ID 338227. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 7; records 151–200 of 313 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467491076?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JEFF R PETERSON, NPI 1467491076, CMS profile ID 338227. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 7; records 151–200 of 313 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467491076?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JEFF R PETERSON, NPI 1467491076, CMS profile ID 338227, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 7; records 151–200 of 313 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1467491076?year=2021&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

313 matching records · $205,564.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 313 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 313.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $6.4007/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788280921 CMS
Horizon Therapeutics plc $675.0007/21/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185753 CMS
Lilly USA, LLC $18.9207/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818563659 CMS
Janssen Biotech, Inc. $5.9707/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788280907 CMS
Novartis Pharmaceuticals Corporation $51.8607/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813160919 CMS
E.R. Squibb & Sons, L.L.C. $13.7107/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783590197 CMS
Horizon Therapeutics plc $1,350.0007/15/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185751 CMS
Horizon Therapeutics plc $900.0007/14/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185749 CMS
Horizon Therapeutics plc $125.0007/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185737 CMS
Horizon Therapeutics plc $7,020.0007/13/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185739 CMS
Horizon Therapeutics plc $97.8707/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185741 CMS
Horizon Therapeutics plc $170.8207/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185743 CMS
Horizon Therapeutics plc $476.8007/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185745 CMS
Horizon Therapeutics plc $431.0607/13/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185747 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $16.6107/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851889767 CMS
Horizon Therapeutics plc $123.4507/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185727 CMS
Horizon Therapeutics plc $7,020.0007/09/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185729 CMS
Horizon Therapeutics plc $81.1207/09/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185731 CMS
Horizon Therapeutics plc $871.8007/09/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185733 CMS
Horizon Therapeutics plc $262.5607/09/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185735 CMS
UCB, Inc. $17.3607/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807369701 CMS
Lilly USA, LLC $1,437.5007/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818553237 CMS
Lilly USA, LLC $575.0007/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818562679 CMS
AbbVie Inc. $23.3707/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795617559 CMS
Novartis Pharmaceuticals Corporation $5.3407/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813160939 CMS
Janssen Biotech, Inc. $23.5306/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788280879 CMS
Lilly USA, LLC $575.0006/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818562163 CMS
Horizon Therapeutics plc $2,173.0006/28/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185717 CMS
Horizon Therapeutics plc $675.0006/28/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185719 CMS
Horizon Therapeutics plc $3,240.0006/28/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185721 CMS
Horizon Therapeutics plc $81.7606/28/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185723 CMS
Horizon Therapeutics plc $106.0106/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185725 CMS
Lilly USA, LLC $1,150.0006/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819142419 CMS
AstraZeneca Pharmaceuticals LP $22.4206/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829888495 CMS
Horizon Therapeutics plc $2.0906/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185715 CMS
Horizon Therapeutics plc $1.9806/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185713 CMS
Horizon Therapeutics plc $29.8006/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185711 CMS
Alexion Pharmaceuticals, Inc. $24.5206/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783116583 CMS
Horizon Therapeutics plc $1,350.0006/16/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185709 CMS
Horizon Therapeutics plc $675.0006/14/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185707 CMS
Horizon Therapeutics plc $2,106.0006/11/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185705 CMS
Horizon Therapeutics plc $7,020.0006/10/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185687 CMS
Horizon Therapeutics plc $124.0006/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185689 CMS
Horizon Therapeutics plc $322.0406/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185691 CMS
Horizon Therapeutics plc $821.1006/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185693 CMS
Horizon Therapeutics plc $4,212.0006/10/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185695 CMS
Horizon Therapeutics plc $58.0406/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185697 CMS
Horizon Therapeutics plc $540.2706/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185699 CMS
Horizon Therapeutics plc $39.2406/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185701 CMS
Horizon Therapeutics plc $113.5206/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185703 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $295,180.31 515
PY2020 $161,742.89 289
PY2021 $205,564.86 313
PY2022 $1,177,878.94 331
PY2023 $197,728.96 323
PY2024 $146,205.17 272
PY2025 $124,838.54 246

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $88,843.67 6
PY2024 Recipient $2,040.02 1
PY2024 Principal investigator $96,259.99 8
PY2023 Recipient $7,358.83 1
PY2023 Principal investigator $71,432.59 7
PY2022 Recipient $1,308.00 1
PY2022 Principal investigator $58,274.00 2
PY2021 Principal investigator $85,770.00 3
PY2020 Recipient $1,205.00 1
PY2020 Principal investigator $83,297.09 10
PY2019 Principal investigator $231,588.62 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $8,695.81 06/12/2025 Non-covered Recipient Entity
WESTERN WASHINGTON MEDICAL GROUP
A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjgren's Syndrome (SS) No dispute reported 06/30/2026 1246652244
Principal investigator 1 Amgen Inc. $31,083.70 05/08/2025 Non-covered Recipient Entity
WESTERN WASHINGTON MEDICAL GROUP
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246652248
Principal investigator 1 Eli Lilly and Company $3,862.00 02/18/2025 Non-covered Recipient Entity
SOUND CLINICAL RESEARCH, LLC
A PHASE 2B DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE PERESOLIMAB IN ADULT PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187891338
Principal investigator 1 Amgen Inc. $8,070.68 02/10/2025 Non-covered Recipient Entity
SOUND CLINICAL RESEARCH, LLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246648334
Principal investigator 1 Amgen Inc. $31,779.15 01/28/2025 Non-covered Recipient Entity
WESTERN WASHINGTON MEDICAL GROUP, BOTHELL - RHEUMATOLOGY
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgrens Syndrome With Moderate-to-Severe Systemic Disease Activity No dispute reported 06/30/2026 1246652240
Principal investigator 1 Amgen Inc. $5,352.33 01/06/2025 Non-covered Recipient Entity
WEST BROWARD RHEUMATOLOGY ASSOCIATES, INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246652068